Founded in 2015 and headquartered in New York, Syno Capital has a track record of investing in healthcare companies and has a particular interest in the fields of health diagnostics and pharmaceuticals. The firm typically invests in rounds with 7-8 participants and has a preference for startups that are 4-5 years old. Syno Capital has a strong presence in the United States and also helps its portfolio companies expand into the Greater China region, leveraging its extensive network of strategic partners in China to accelerate their growth both domestically and internationally.